S.175 (Act 133)

An act relating to the wholesale importation of prescription drugs into Vermont

Sponsors: Sen. Timothy Ashe, Sen. Claire Ayer, Sen. Virginia Lyons, Sen. Christopher Pearson, Sen. Michael Sirotkin

Last Recorded Action: 5/12/2018 - Signed by Governor on May 16, 2018

Committee Activity - Meeting Full List

2017-2018 Legislative Session
Thursday, January 18, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Sen. Tim Ashe, Sponsor
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Peter Welch, U.S. Congressman, Vermont
John Tracy, Field Representative, Office of Senator Patrick Leahy
Trish Riley, Executive Director, National Academy of State Health Policy
Friday, January 26, 2018
Committee(s):
Senate Committee on Health and Welfare
9:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Kevin Mullin, Chair, Green Mountain Care Board
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Nate Awrich, Manager of Pharmacy Operations, University of Vermont Health Network
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Rebecca Heintz, General Counsel, Blue Cross/Blue Shield of Vermont
Mark Hage, Member Benefits Director, Vermont-NEA
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists
Tuesday, January 30, 2018
Committee(s):
Senate Committee on Health and Welfare
11:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America PhRMA
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
11:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion and Possible Mark-up

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Susan Barrett, Executive Director, Green Mountain Care Board
Friday, February 2, 2018
Committee(s):
Senate Committee on Health and Welfare
10:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Susan Barrett, Executive Director, Green Mountain Care Board
Jamie Feehan, Lobbyist, Property & Casualty Insurance Association and State Farm
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Tuesday, February 6, 2018
Committee(s):
Senate Committee on Health and Welfare
`

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion, Possible Mark-up and Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Wednesday, February 7, 2018
Committee(s):
Senate Committee on Health and Welfare
9:45 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion and Possible Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
Friday, February 9, 2018
Committee(s):
Senate Committee on Finance
2:30 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Walk thru of bill by drafter

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
Tuesday, February 13, 2018
Committee(s):
Senate Committee on Finance
2:30 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Possible Vote

Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Friday, February 23, 2018
Committee(s):
Senate Committee on Appropriations
1:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Sen. Claire Ayer
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Thursday, March 15, 2018
Committee(s):
House Committee on Health Care
10:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Walk-through with Legislative Counsel

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Continue walk-through of the bill.

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Thursday, March 22, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Overview; Sec. 1 of the bill--importation of prescription drugs; fiscal note.

Sen. Tim Ashe, Sponsor
John Tracy, Field Representative, Office of Senator Patrick Leahy
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Peter Welch, U.S. Congressman, Vermont
Trish Riley, Executive Director, National Academy of State Health Policy
Jane Horvath, National Academy of State Health Policy
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Bernie Sanders, U.S. Senator
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Friday, March 23, 2018
Committee(s):
House Committee on Health Care
8:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Background; prescription drug transparency; reports from the Attorney General's Office

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jill Abrams, Assistant Attorney General, Attorney General's Office
Wednesday, March 28, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Sec. 1, Importation of drugs, continued; Section 2, Bulk purchasing

Cory Gustafson, Commissioner, Department of Vermont Health Access (DVHA)
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
10:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Section 6: "Gag rule"

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jeff Hochberg, President, Vermont Retail Druggists
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Jamie Feehan, Lobbyist, CVS/Caremark
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Thursday, March 29, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Testimony on Sections 3 and 4 --Health Insurance Plan Reporting; Impact of Prescription Drug Costs on Health Insurance Premiums

Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Susan Barrett, Executive Director, Green Mountain Care Board
Kevin Mullin, Chair, Green Mountain Care Board
Wednesday, April 4, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, April 5, 2018
Committee(s):
House Committee on Health Care
11:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Review draft and Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Wednesday, April 11, 2018
Committee(s):
House Committee on Health Care
9:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
10:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion; follow-up from work group on current prescription drug pricing law.

Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Jill Abrams, Assistant Attorney General, Attorney General's Office
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Bridget Morris, Lobbyist, Association for Accessible Medicines
Thursday, April 12, 2018
Committee(s):
House Committee on Ways and Means
9:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Thursday, April 12, 2018
Committee(s):
House Committee on Health Care
3:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Focus on drug importation & bulk purchasing

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 13, 2018
Committee(s):
House Committee on Health Care
11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion (S.262 discussion postponed to next week)

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
2:15 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Final markup and possible vote. S.175 only.
Time changed to 2:15 PM or after discussion on S.92

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Wednesday, April 18, 2018
Committee(s):
House Committee on Ways and Means
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
3:15 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Al Gobeille, Secretary, Agency of Human Services
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, April 19, 2018
Committee(s):
House Committee on Ways and Means
After the Floor

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 20, 2018
Committee(s):
House Committee on Ways and Means
9:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

potential vote

Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Friday, April 20, 2018
Committee(s):
House Committee on Health Care
--After the Floor

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Bill As Recommended by House Ways and Means Committee.
https://legislature.vermont.gov/assets/Documents/2018/WorkGroups/House%20Health%20Care/Bills/S.175/S.175~House%20Ways%20and%20Means%20Committee~S.175,%20As%20Recommended%20by%20House%20Ways%20and%20Means%20Committee~4-20-2018.pdf

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Rep. George W. Till
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Tuesday, April 24, 2018
Committee(s):
House Committee on Health Care
1:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion: Amendment from House Ways and Means

Rep. Mary S. Hooper, Sponsor of amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, April 25, 2018
Committee(s):
House Committee on Appropriations
11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Rep. William J. Lippert, Chair, House Committee on Health Care
Thursday, April 26, 2018
Committee(s):
Senate Committee on Health and Welfare
8:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee Discussion

Thursday, May 3, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Monday, May 7, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Sen. Michael Sirotkin, Reporter, Senate Committee on Finance